DNA methylation and cognitive aging

Oncotarget

Volumn 6, Issue 16, 2015, Pages 13925-13934

  Xu, Xiangru ^a,b  

^a MAX PLANCK INSTITUTE FOR BIOLOGY OF AGEING   (Germany)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bisulfite DNA methyl sequencing; Epigenetics; Neurodegeneration; Neuronal genes; Transcriptional regulation

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; HISTONE DEACETYLASE; HISTONE H3; HISTONE H3K27ME3; HISTONE H3K9ME3; HISTONE H4; HISTONE H4K12AC; HISTONE METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE EZH2; MAMMALIAN TARGET OF RAPAMYCIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG; DNA; DNA FRAGMENT; GENOMIC DNA;

AGING; ARTICLE; CHROMATIN STRUCTURE; COGNITION; CPG ISLAND; DNA METHYLATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE REPRESSION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HISTONE ACETYLATION; HUMAN; LONG TERM DEPRESSION; LONG TERM MEMORY; NANOG GENE; NERVE CELL PLASTICITY; NONHUMAN; OCT4 GENE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROCESSING; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; COGNITIVE AGING; GENETIC EPIGENESIS; PHYSIOLOGY; BRAIN CORTEX; COGNITIVE DEFECT; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENETIC MANIPULATION; GENOME; GENOME-WIDE ASSOCIATION STUDY; HIPPOCAMPUS; INCIDENCE; LONG TERM POTENTIATION; MEMORY; NERVE DEGENERATION; PATHOGENESIS; SPATIAL LEARNING;

ANIMALS; COGNITIVE AGING; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS;

EID: 84931065087     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4215     Document Type: Article

References (96)

1. Xu X. Single cell transcriptome study in brain aging. Single Cell Biol 1:e111
2. Scott KR, Barrett AM. Dementia syndromes: evaluation and treatment. Expert Rev Neurother. 2007 Apr 7:407-22.
3. Bach ME, Barad M, Son H, Zhuo M, Lu YF, Shih R, Mansuy I, Hawkins RD, Kandel ER. Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway. Proc Natl Acad Sci U S A, 1999. 96:5280-5.
4. Rosenzweig ES and Barnes CA. Impact of aging on hippocampal function: plasticity, network dynamics, and cognition. Prog Neurobiol, 2003. 69:143-79.
5. Brody H. Organization of the cerebral cortex. III. A study of aging in the human cerebral cortex. J Comp Neurol, 1955. 102:511-6.
6. Scheibel ME, Lindsay RD, Tomiyasu U, Scheibel AB. Progressive dendritic changes in the aging human limbic system. Exp Neurol, 1976. 53:420-30.
7. Scheibel AB. The hippocampus: organizational patterns in health and senescence. Mech Ageing Dev, 1979. 9:89-102.
8. Burke SN and Barnes CA. Neural plasticity in the ageing brain. Nat Rev Neurosci, 2006. 7:30-40.
9. Gutchess A. Plasticity of the aging brain: new directions in cognitive neuroscience. Science. 2014 Oct 31;346:579-82
10. Schimanski LA, Barnes CA. Neural Protein Synthesis during Aging: Effects on Plasticity and Memory. Front Aging Neurosci. 2010 Aug 6;2. pii: 26.
11. McGowan PO, Meaney MJ, Szyf M. Diet and the epigenetic (re)programming of phenotypic differences in behavior. Brain Res. 2008 Oct 27;1237:12-24
12. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature. 2004 Aug 5;430:631-9.
13. Verstraeten A, Theuns J, Van Broeckhoven C. Progress in unraveling the genetic etiology of Parkinson disease in a genomic era. Trends Genet. 2015 Mar;31:140-9.
14. Lu L, Neff F, Dun Z, Hemmer B, Oertel WH, Schlegel J, Hartmann A. Gene expression profiles derived from single cells in human postmortem brain. Brain Res Brain Res Protoc, 2004. 13:18-25.
15. Xu X, Zhan M, Duan W, Prabhu V, Brenneman R, Wood W, Firman J, Li H, Zhang P, Ibe C, Zonderman AB, Longo DL, Poosala S, Becker KG, Mattson MP. Gene expression atlas of the mouse central nervous system: impact and interactions of age, energy intake and gender. Genome Biol, 2007. 8: R234.
16. Rowe WB, Blalock EM, Chen KC, Kadish I, Wang D, Barrett JE, Thibault O, Porter NM, Rose GM, Landfield PW. Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats. J Neurosci, 2007. 27:3098-110.
17. Cajal RY. The Croonian Lecture: La Fine Structure des Centres Nerveux. Proc Roy Soc London, 1894. 55:444-448.
18. Burger C. Region-specific genetic alterations in the aging hippocampus: implications for cognitive aging. Front Aging Neurosci. 2:140.
19. Zeier Z, Madorsky I, Xu Y, Ogle WO, Notterpek L, Foster TC. Gene expression in the hippocampus: regionally specific effects of aging and caloric restriction. Mech Ageing Dev. 132:8-19.
20. Wang X, Michaelis EK. Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci. 2010 Mar 30;2:12.
21. Wang X, Michaelis ML, Michaelis EK. Functional genomics of brain aging and Alzheimer's disease: focus on selective neuronal vulnerability. Curr Genomics. 2010 Dec;11:618-33.
22. O'Keefe J and Dostrovsky J. The hippocampus as a spatial map. Preliminary evidence from unit activity in the freely-moving rat. Brain Res, 1971. 34:171-5.
23. Jung MW and McNaughton BL. Spatial selectivity of unit activity in the hippocampal granular layer. Hippocampus, 1993. 3:165-82.
24. Wilson MA and McNaughton BL. Dynamics of the hippocampal ensemble code for space. Science, 1993. 261:1055-8.
25. Bland BH, Konopacki J, and Dyck R. Heterogeneity among hippocampal pyramidal neurons revealed by their relation to theta-band oscillation and synchrony. Exp Neurol, 2005. 195:458-74.
26. Bahar R, Hartmann CH, Rodriguez KA, Denny AD, Busuttil RA, Dollé ME, Calder RB, Chisholm GB, Pollock BH, Klein CA, Vijg J. Increased cell-to-cell variation in gene expression in ageing mouse heart. Nature. 2006 Jun 22;441:1011-4.
27. Busuttil R, Bahar R, Vijg J. Genome dynamics and transcriptional deregulation in aging. Neuroscience. 2007 Apr 14;145:1341-7.
28. Duan W, Guo Z, Jiang H, Ware M, Li XJ, Mattson MP. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc Natl Acad Sci U S A, 2003. 100:2911-6.
29. Halagappa VK, Guo Z, Pearson M, Matsuoka Y, Cutler RG, Laferla FM, Mattson MP. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol Dis, 2007. 26:212-20.
30. Maalouf M, Rho JM and Mattson MP. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev, 2009. 59:293-315.
31. Stranahan AM, Lee K, Martin B, Maudsley S, Golden E, Cutler RG, Mattson MP. Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice. Hippocampus, 2009. 19:951-61.
32. Martin B, Pearson M, Brenneman R, Golden E, Keselman A, Iyun T, Carlson OD, Egan JM, Becker KG, Wood W 3rd, Prabhu V, de Cabo R, Maudsley S, Mattson MP. Conserved and differential effects of dietary energy intake on the hippocampal transcriptomes of females and males. PLoS One, 2008. 3: e2398.
33. Bjedov I, Toivonen JM, Kerr F, Slack C, Jacobson J, Foley A, Partridge L. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab. 2010 Jan;11:35-46.
34. Kaeberlein M, Powers RW 3rd, Steffen KK, Westman EA, Hu D, Dang N, Kerr EO, Kirkland KT, Fields S, Kennedy BK. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science. 2005 Nov 18;310:1193-6.
35. Kapahi P, Zid BM, Harper T, Koslover D, Sapin V, Benzer S. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol. 2004 May 25;14:885-90.
36. Medvedik O, Lamming DW, Kim KD, Sinclair DA.MSN2 and MSN4 link calorie restriction and TOR to sirtuin-mediated lifespan extension in Saccharomyces cerevisiae. PLoS Biol. 2007 Oct 2;5:e261.
37. Vellai T, Takacs-Vellai K, Zhang Y, Kovacs AL, Orosz L, Müller F. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature. 2003 Dec 11;426:620.
38. Harrison DE, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009 Jul 16;460:392-5.
39. Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, Fernandez E, Flurkey K, Javors MA, Nelson JF, Orihuela CJ, Pletcher S, Sharp ZD, Sinclair D, Starnes JW, Wilkinson JE, Nadon NL, Strong R. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2011 Feb;66:191-201
40. Wilkinson JE, Burmeister L, Brooks SV, Chan CC, Friedline S, Harrison DE, Hejtmancik JF, Nadon N, Strong R, Wood LK, Woodward MA, Miller RA. 2012. Rapamycin Slows Aging in Mice. Aging Cell 11:675-82.
41. Majumder S, Caccamo A, Medina DX, Benavides AD, Javors MA, Kraig E, Strong R, Richardson A, Oddo S. Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1ß and enhancing NMDA signaling. Aging Cell. 2012 Apr 11:326-35
42. Halloran J, Hussong SA, Burbank R, Podlutskaya N, Fischer KE, Sloane LB, Austad SN, Strong R, Richardson A, Hart MJ, Galvan V. Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice. Neuroscience. 2012 Oct 25;223:102-13.
43. Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, Richardson A, Strong R, Galvan V. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One. 2010 Apr 1;5:e9979.
44. Wu JJ, Liu J, Chen EB, Wang JJ, Cao L, Narayan N, Fergusson MM, Rovira II, Allen M, Springer DA, Lago CU, Zhang S, DuBois W, Ward T, deCabo R, Gavrilova O, Mock B, Finkel T. Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression. Cell Rep. 2013 Sep 12;4:913-20.
45. Qian H, Xu X. Reduction in DNA methyltransferases and alteration of DNA methylation pattern associate with mouse skin ageing. Exp Dermatol. 2014 May;23:357-9.
46. Wu SC, Zhang Y. Active DNA demethylation: Many roads lead to Rome. Nat Rev Mol Cell Biol. 2010; Sep;11:607-20.
47. He XJ, Chen T, Zhu JK. Regulation and function of DNA methylation in plants and animals. Cell Res. 2011 Mar;21:442-65.
48. Feng J, Zhou Y, Campbell SL, Le T, Li E, Sweatt JD, Silva AJ, Fan G. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci. 2010 Apr 13:423-30.
49. Proffitt JH, Davie JR, Swinton D, Hattman S. 5-Methylcytosine is not detectable in Saccharomyces cerevisiae DNA. Mol Cell Biol. 1984 May;4:985-8.
50. V J Simpson, T E Johnson, and R F Hammen. Caenorhabditis elegans DNA does not contain 5-methylcytosine at any time during development or aging. Nucleic Acids Res. 1986; 14: 6711-6719.
51. Doerfler W. DNA methylation and gene activity. Annu Rev Biochem. 1983;52:93-124.
52. Ito S, Shen L, Dai Q, Wu SC, Collins LB, Swenberg JA, He C, Zhang Y. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. 2011 Sep 2;333:1300-3.
53. He YF, Li BZ, Li Z, Liu P, Wang Y, Tang Q, Ding J, Jia Y, Chen Z, Li L, Sun Y, Li X, Dai Q, Song CX, Zhang K, He C, Xu GL. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science. 2011 Sep 2;333:1303-7.
54. Nabel CS, Kohli RM. Molecular biology. Demystifying DNA demethylation. Science. 2011 Sep 2;333:1229-30.
55. Wilson VL, Smith RA, Ma S, Cutler RG. Genomic 5-methyldeoxycytidine decreases with age. J Biol Chem. 1987 Jul 25;262:9948-51.
56. Singhal RP, Mays-Hoopes LL, Eichhorn GL. DNA methylation in aging of mice. Mech Ageing Dev. 1987 Dec;41:199-210.
57. Wilson VL, Jones PA. DNA methylation decreases in aging but not in immortal cells. Science. 1983 Jun 3;220:1055-7.
58. Dong E1, Chen Y, Gavin DP, Grayson DR, Guidotti A. Valproate induces DNA demethylation in nuclear extracts from adult mouse brain. Epigenetics. 2010 Nov-Dec;5:730-5.
59. Klein CJ, Botuyan MV, Wu Y, et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet 2011, 43:595-600.
60. Kaas GA, Zhong C, Eason DE, Ross DL, Vachhani RV, Ming GL, King JR, Song H, Sweatt JD. TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation. Neuron. 2013 Sep 18;79:1086-93.
61. Klein CJ, Botuyan MV, Wu Y, et al. Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet 2011, 43:595-600.
62. Oliveira AM, Hemstedt TJ, Bading H. Rescue of aging-associated decline in Dnmt3a2 expression restores cognitive abilities. Nat Neurosci. 2012 Jul 1;15:1111-3
63. Su SC, Tsai LH. DNA methylation in cognition comes of age. Nat Neurosci. 2012 Jul 26;15:1061-2.
64. Penner MR, Roth TL, Barnes CA, Sweatt JD. An Epigenetic Hypothesis of Aging-Related Cognitive Dysfunction. Front Aging Neurosci. 2010; 2: 9.
65. Akbarian S, Beeri MS, Haroutunian V. Epigenetic determinants of healthy and diseased brain aging and cognition. JAMA Neurol. 2013 Jun;70:711-8.
66. Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NC, Schreiber SL, Mellor J, Kouzarides T. Active genes are tri-methylated at K4 of histone H3. Nature. 2002; 419: 407-411.
67. Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell. 2007 Feb 23;128:635-8.
68. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007;129:823-837.
69. Fischer A, Sananbenesi F, Mungenast A, Tsai LH. Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol Sci. 2010 Dec;31:605-17.
70. Haggarty SJ and Tsai LH. Probing the role of HDACs and mechanisms of chromatin-mediated neuroplasticity. Neurobiol Learn Mem 96: 41-52.
71. Gupta S, Kim SY, Artis S, Molfese DL, Schumacher A, Sweatt JD, Paylor RE, Lubin FD. Histone methylation regulates memory formation. J Neurosci. 2010 Mar 10;30(10):3589-99.
72. Qureshi IA1, Mehler MF. Non-coding RNA networks underlying cognitive disorders across the lifespan. Trends Mol Med. 2011 Jun;17:337-46.
73. Gong H, Qian H, Ertl R, Astle MC, Wang GG, Harrison DE, Xu X. Histone modifications change with age, dietary restriction and rapamycin treatment in mouse brain. Oncotarget (in press)
74. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schübeler D. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet. 2005 Aug;37:853-62.
75. Meissner A, Gnirke A, Bell GW, Ramsahoye B, Lander ES, Jaenisch R. Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res. 2005 Oct 13;33:5868-77.
76. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011 May 15;25:1010-22
77. Smallwood SA, Kelsey G. Genome-wide analysis of DNA methylation in low cell numbers by reduced representation bisulfite sequencing. Methods Mol Biol. 2012;925:187-97.
78. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM, Edsall L, Antosiewicz-Bourget J, Stewart R, Ruotti V, Millar AH, Thomson JA, Ren B, Ecker JR. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009 Nov 19;462:315-22.
79. Rivera CM, Ren B. Mapping human epigenomes. Cell. 2013 Sep 26;155:39-55.
80. Pan X, Durrett RE, Zhu H, Tanaka Y, Li Y, Zi X, Marjani SL, Euskirchen G, Ma C, Lamotte RH, Park IH, Snyder MP, Mason CE, Weissman SM. Two methods for full-length RNA sequencing for low quantities of cells and single cells. Proc Natl Acad Sci U S A. 2013 Jan 8;110:594-9
81. Guo H, Zhu P, Guo F, Li X, Wu X, Fan X, Wen L, Tang F. Profiling DNA methylome landscapes of mammalian cells with single-cell reduced-representation bisulfite sequencing. Nat Protoc. 2015 May;10:645-59.
82. Guo H, Zhu P, Wu X, Li X, Wen L, Tang F. Single-cell methylome landscapes of mouse embryonic stem cells and early embryos analyzed using reduced representation bisulfite sequencing. Genome Res. 2013 Dec;23:2126-35.
83. Smallwood SA, Lee HJ, Angermueller C, Krueger F, Saadeh H, Peat J, Andrews SR, Stegle O, Reik W, Kelsey G. Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity. Nat Methods. 2014 Aug;11:817-20.
84. Sanchez MM, Das D, Taylor JL, et al. BDNF polymorphism predicts the rate of decline in skilled task performance and hippocampal volume in healthy individuals. Transl Psychiatry. 2011 Oct 25;1:e51.
85. Baker SA, Stanford LE, Brown RE, Hagg T. Maturation but not survival of dopaminergic nigrostriatal neurons is affected in developing and aging BDNF-deficient mice. Brain Res. 2005 Mar 28;1039:177-88.
86. Heldt SA, Stanek L, Chhatwal JP, Ressler KJ. Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry. 2007 Jul;12:656-70.
87. Hebda-Bauer EK, Luo J, Watson SJ, Akil H. Female CREBalphadelta- deficient mice show earlier age-related cognitive deficits than males. Neuroscience. 2007 Dec 5;150:260-72.
88. Penner MR, Roth TL, Chawla MK, et al. Age-related changes in Arc transcription and DNA methylation within the hippocampus. Neurobiol Aging. 2011 Dec;32:2198-210.
89. Lister R, Pelizzola M, Dowen RH, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009 Nov 19;462:315-22.
90. Buckley NJ, Johnson R, Zuccato C, et al. The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease. Neurobiol Dis. 2010 Jul;39:28-39.
91. Miller-Delaney SF, Bryan K, Das S, McKiernan RC, Bray IM, Reynolds JP, Gwinn R, Stallings RL, Henshall DC. Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy. Brain. 2015 Mar;138:616-31
92. Mattson MP. Lifelong brain health is a lifelong challenge: from evolutionary principles to empirical evidence. Ageing Res Rev. 2015 Mar;20:37-45
93. Penney J, Tsai LH. Histone deacetylases in memory and cognition. Sci Signal. 2014 Dec 9;7:re12
94. Kosik KS, Rapp PR, Raz N, et al. Mechanisms of age-related cognitive change and targets for intervention: epigenetics. J Gerontol A Biol Sci Med Sci. 2012 Jun; 67:741-6.
95. Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet. 2009 May;10:295-304.
96. Reik W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature. 2007 May 24;447:425-32.